These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10175148)

  • 21. Accumulated cytokines in stored autologous blood do not cause febrile nonhemolytic transfusion reactions.
    Tasaki T; Gotoh K; Fujii K; Sasaki S; Satoh S; Takadate J; Otsubo H; Hoshi Y
    Transfus Apher Sci; 2008 Aug; 39(1):15-9. PubMed ID: 18585093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The preparation of platelet concentrates by the light-spin/hard-spin technique.
    Dzik WH
    Transfus Sci; 1991; 12(3):171-81. PubMed ID: 10149546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of leukocyte-reduction on the transfusion reactions to red blood cells concentrates].
    Mukagatare I; Monfort M; de Marchin J; Gerard C
    Transfus Clin Biol; 2010 Feb; 17(1):14-9. PubMed ID: 20106700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
    Seghatchian J
    Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokines in Platelet Concentrates.
    Heddle NM
    Hematology; 1997; 2(6):473-84. PubMed ID: 27415844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions.
    Heddle NM; Klama LN; Griffith L; Roberts R; Shukla G; Kelton JG
    Transfusion; 1993 Oct; 33(10):794-7. PubMed ID: 8236418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transfusion-refractory thrombocytopenia during chemotherapy: pathogenesis, frequency and treatment].
    Helleberg C; Taaning EB; Johnsen HE
    Ugeskr Laeger; 1995 Sep; 157(37):5082-6. PubMed ID: 7502374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Removal by adsorbent beads of biological response modifiers released from platelets, accumulated during storage, and potentially associated with platelet transfusion reactions.
    Tanaka S; Hayashi T; Tani Y; Hirayama F
    Transfusion; 2010 May; 50(5):1096-105. PubMed ID: 20051054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 1 beta and tumor necrosis factor levels in stored platelet concentrates and the association with gene polymorphisms.
    Addas-Carvalho M; Origa AF; Saad ST
    Transfusion; 2004 Jul; 44(7):996-1003. PubMed ID: 15225239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The febrile platelet transfusion reaction: a cytokine shower.
    Ferrara JL
    Transfusion; 1995 Feb; 35(2):89-90. PubMed ID: 7825217
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of filtration on platelet transfusion reactions. Northern Ireland Haematology Audit Group [corrected].
    Morris K; Bharucha C
    Eur J Med Res; 1997 Dec; 2(12):523-6. PubMed ID: 9426262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
    Corash L
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of transfusion reactions associated with prestorage-pooled platelet components.
    Tormey CA; Sweeney JD; Champion MH; Pisciotto PT; Snyder EL; Wu Y
    Transfusion; 2009 Jun; 49(6):1242-7. PubMed ID: 19389029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system.
    Riggert J; Humpe A; Simson G; Köhler M
    Vox Sang; 1998; 74(3):182-8. PubMed ID: 9595646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactions.
    Patterson BJ; Freedman J; Blanchette V; Sher G; Pinkerton P; Hannach B; Meharchand J; Lau W; Boyce N; Pinchefsky E; Tasev T; Pinchefsky J; Poon S; Shulman L; MacK P; Thomas K; Blanchette N; Greenspan D; Panzarella T
    Transfus Med; 2000 Sep; 10(3):199-206. PubMed ID: 10972914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Febrile reactions in platelet transfusion recipients.
    Kakaiya R; Gudino M; Miller WV
    Transfusion; 1990 Oct; 30(8):765-6. PubMed ID: 2219265
    [No Abstract]   [Full Text] [Related]  

  • 39. Febrile neutropenia contributes to underreporting of potential septic platelet transfusion reactions.
    Olsen KE; Sandler SG
    Vox Sang; 1996; 70(2):118. PubMed ID: 8801761
    [No Abstract]   [Full Text] [Related]  

  • 40. Adverse effects of 'old' versus 'young' blood: also true for platelet concentrates?
    van der Meer PF
    Clin Lab; 2011; 57(3-4):260-2. PubMed ID: 21500737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.